The global remote patient monitoring systems market size is expected to reach around US$ 4.5 billion by 2030 from US$ 965 million in 2021 and is expected to grow at an impressive double-digit rate of 4.5% from 2021 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global remote patient monitoring systems market for the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2020 is considered as the base year.
The increasing adoption of digital technologies in the global healthcare industry is significantly driving the remote patient monitoring (RPM) systems market. Further, the rising prevalence of various deadly diseases, growing geriatric population, and increasing incidences of road accidents is boosting the growth of the global RPM systems market. The demand for the RPM systems is rapidly growing among the old age population as this age group needs continuous monitoring of their health conditions
We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1390
COVID-19 Impact on the RPM (Remote Patient Monitoring) Market:
COVID-19 Outbreak in 2019 has positively affected the market of the remote patient monitoring industry. To avoid the spread of virus, healthcare facilities and patients prefer to avoid physical visits to hospitals. Hence, many hospitals and healthcare facilities has implemented a remote patient monitoring system to keep track of a patient’s health.
Furthermore, large number of COVID infected patients were home isolated and hence they need to keep a track of oxygen level and heart rate during isolation at home. All these factors impacted the industry positively and further likely to grow with a significant rate during the forecast period.
Resistance and Fraud
Many healthcare professionals are resisting the remote patient monitoring system as the dependency of the patients on them will reduce which may affect their professional growth. The healthcare professionals often advise the patients against this system which may hamper the growth of the market.
Also, healthcare fraud in telehealth and telemedicine practices can hinder the market growth as issues related to fraudulent reimbursement claims, billing cycle, etc. can be prevalent in the market.
Why should you invest in this report?
If you are aiming to enter the global remote patient monitoring systems market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for remote patient monitoring systems are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global remote patient monitoring systems market include:
- Abbott Laboratories
- Aerotel Medical Systems
- AMD Global Telemedicine
- Baxter International Inc.
- Boston Scientific Corporation
- GE Healthcare
- Masimo Corporation
- Medtronic PLC
- F. Hoffmann-La Roche AG
- Omron Corporation
Market Segmentation:
By Product
- Specialized Monitors
- Vital Sign Monitors
By Application
- Diabetes
- Cancer
- Cardiovascular Diseases
- Weight Management
- Bronchitis
- Sleep Disorder
- Dehydration
- Virus
- Hypertension
By End Use
- Hospital Patients
- Ambulatory Patients
- Home Healthcare
Regional Analysis:
The geographical analysis of the global remote patient monitoring systems market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global remote patient monitoring systems Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global remote patient monitoring systems market in 2030?
- What is the expected CAGR for the remote patient monitoring systems market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global remote patient monitoring systems market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Remote Patient Monitoring Systems Market
5.1. COVID-19 Landscape: Remote Patient Monitoring Systems Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Remote Patient Monitoring Systems Market, By Product
8.1. Remote Patient Monitoring Systems Market, by Product Type, 2021-2030
8.1.1. Specialized Monitors
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Vital Sign Monitors
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Remote Patient Monitoring Systems Market, By Application
9.1. Remote Patient Monitoring Systems Market, by Application, 2021-2030
9.1.1. Diabetes
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Cancer
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Cardiovascular Diseases
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Weight Management
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Bronchitis
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Sleep Disorder
9.1.6.1. Market Revenue and Forecast (2019-2030)
9.1.7. Dehydration
9.1.7.1. Market Revenue and Forecast (2019-2030)
9.1.8. Virus
9.1.8.1. Market Revenue and Forecast (2019-2030)
9.1.9. Hypertension
9.1.9.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Remote Patient Monitoring Systems Market, By End Use
10.1. Remote Patient Monitoring Systems Market, by End Use, 2021-2030
10.1.1. Hospital Patients
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Ambulatory Patients
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Home Healthcare
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Remote Patient Monitoring Systems Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.3. Market Revenue and Forecast, by End Use (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.4.3. Market Revenue and Forecast, by End Use (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.5.3. Market Revenue and Forecast, by End Use (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.3. Market Revenue and Forecast, by End Use (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.4.3. Market Revenue and Forecast, by End Use (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.5.3. Market Revenue and Forecast, by End Use (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.6.3. Market Revenue and Forecast, by End Use (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.7.3. Market Revenue and Forecast, by End Use (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.3. Market Revenue and Forecast, by End Use (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.4.3. Market Revenue and Forecast, by End Use (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.5.3. Market Revenue and Forecast, by End Use (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.6.3. Market Revenue and Forecast, by End Use (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.7.3. Market Revenue and Forecast, by End Use (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.3. Market Revenue and Forecast, by End Use (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.4.3. Market Revenue and Forecast, by End Use (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.5.3. Market Revenue and Forecast, by End Use (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.6.3. Market Revenue and Forecast, by End Use (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.7.3. Market Revenue and Forecast, by End Use (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.3. Market Revenue and Forecast, by End Use (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.4.3. Market Revenue and Forecast, by End Use (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.5.3. Market Revenue and Forecast, by End Use (2019-2030)
Chapter 12. Company Profiles
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Aerotel Medical Systems
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. AMD Global Telemedicine
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Baxter International Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Boston Scientific Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. GE Healthcare
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Masimo Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Medtronic PLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. F. Hoffmann-La Roche AG
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Omron Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1390
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
0 Comments